Literature DB >> 29179557

Displacement of Bax by BMF Mediates STARD13 3'UTR-Induced Breast Cancer Cells Apoptosis in an miRNA-Depedent Manner.

Xinwei Guo1,2, Chenxi Xiang1,2, Zhiting Zhang1,2, Feng Zhang1,2, Tao Xi1,2, Lufeng Zheng1,2.   

Abstract

The balance of pro- and antiapoptotic gene expression programs dominates the apoptotic progress of cancer cells. We previously demonstrated that STARD13 3'UTR suppressed breast cancer metastasis via inhibiting epithelial-mesenchymal transition (EMT). However, the roles of STARD13 3'UTR in breast cancer apoptosis remain elusive. Here, we identified that STARD13 3'UTR promoted cell apoptosis in vitro and in vivo. Mechanistically, STARD13 3'UTR acted as a ceRNA for BMF (Bcl-2 modifying factor), thus increasing BMF expression in an miRNA-dependent manner. Meanwhile, STARD13 3'UTR enhanced the interaction of BMF/Bcl-2 to release Bax (Bcl-2 associated X protein) in breast cancer cells. Finally, we verified the ceRNA relationship between STARD13 and BMF in vivo. Collectively, these findings suggest that STARD13 3'UTR could act as a ceRNA for BMF to promote apoptosis and recognize STARD13 3'UTR as a potential therapeutic target in breast cancer cells.

Entities:  

Keywords:  BMF; STARD13; apoptosis; ceRNA

Mesh:

Substances:

Year:  2017        PMID: 29179557     DOI: 10.1021/acs.molpharmaceut.7b00727

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs.

Authors:  Ruixi Hu; Xiaodong Zhu; Chao Chen; Ruijun Xu; Yifan Li; Wei Xu
Journal:  Cell Prolif       Date:  2018-08-07       Impact factor: 6.831

Review 2.  StarD13: a potential star target for tumor therapeutics.

Authors:  Leila Jaafar; Zeinab Chamseddine; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2020-04-09       Impact factor: 4.174

3.  StarD13 differentially regulates migration and invasion in prostate cancer cells.

Authors:  Leila Jaafar; Isabelle Fakhoury; Sahar Saab; Layal El-Hajjar; Wassim Abou-Kheir; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2021-01-09       Impact factor: 4.174

4.  Breast Cancer Prognosis Prediction and Immune Pathway Molecular Analysis Based on Mitochondria-Related Genes.

Authors:  Weixu Luo; Yuanshan Han; Xin Li; Zhuo Liu; Pan Meng; Yuhong Wang
Journal:  Genet Res (Camb)       Date:  2022-05-31       Impact factor: 1.375

5.  STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells.

Authors:  Fei Gao; Xiaolin Yu; Rongqin Meng; Jisheng Wang; Lin Jia
Journal:  Onco Targets Ther       Date:  2018-08-31       Impact factor: 4.147

6.  DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway.

Authors:  Zheng Yang; Hanrui Chen; Man Shu; Yunjian Zhang; Ling Xue; Yuan Lin
Journal:  Oncol Lett       Date:  2018-12-28       Impact factor: 2.967

7.  MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2.

Authors:  Yingjun Zhang; Weijian Lin; Weiping Jiang; Zhenfa Wang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

8.  MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis.

Authors:  Haiwei Ni; Hai Qin; Cheng Sun; Yichen Liu; Guojing Ruan; Qianqian Guo; Tao Xi; Yingying Xing; Lufeng Zheng
Journal:  Stem Cell Res Ther       Date:  2021-06-05       Impact factor: 6.832

9.  Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis.

Authors:  Xiaoman Li; Qi Jia; Yinyin Zhou; Xuan Jiang; Li Song; Yuanyuan Wu; Aiyun Wang; Wenxing Chen; Shijun Wang; Yin Lu
Journal:  Exp Hematol Oncol       Date:  2022-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.